RT Journal Article
SR Electronic
T1 SARS-CoV-2 detection in nasopharyngeal throat swabs by metagenomics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.24.20110205
DO 10.1101/2020.05.24.20110205
A1 Tan, Le Van
A1 Hong, Nguyen Thi Thu
A1 Ngoc, Nghiem My
A1 Thanh, Tran Tan
A1 Lam, Vo Thanh
A1 Nguyet, Lam Anh
A1 Nhu, Le Nguyen Truc
A1 Ny, Nguyen Thi Han
A1 Minh, Ngo Ngoc Quang
A1 Man, Dinh Nguyen Huy
A1 Hang, Vu Thi Ty
A1 Khanh, Phan Nguyen Quoc
A1 Xuan, Tran Chanh
A1 Phong, Nguyen Thanh
A1 Tu, Tran Nguyen Hoang
A1 Hien, Tran Tinh
A1 Hung, Le Manh
A1 Truong, Nguyen Thanh
A1 Yen, Lam Minh
A1 Dung, Nguyen Thanh
A1 Thwaites, Guy
A1 Chau, Nguyen Van Vinh
A1 for OUCRU COVID-19 research group
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.24.20110205.abstract
AB Metagenomics could detect SARS-CoV-2 in all eight nasopharyngeal/throat swabs with high/low viral loads, and rhinovirus in a co-infected patient. The sequenced viruses belonged to lineage B1. Because metagenomics could detect novel pathogen and co-infection, and generate sequence data for epidemiological investigation, it is an attractive approach for infectious-disease diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Wellcome Trust of Great Britain (106680/B/14/Z and 204904/Z/16/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of the HTD and the Oxford Tropical Research Ethics Committee of the University of OxfordAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesProvided with in the ms is the essential information. Additional information will be available upon reasonable request.